Relationship of HS CRP and sacroiliac joint inflammation in undifferentiated spondyloarthritis

Te-Jung Liu; Cheng-Chiang Chang; Liang-Cheng Chen; Heng-Yi Chu; Chun-Sheng Hsu; Shin-Tsu Chang

doi:10.1515/med-2018-0018

Artikel Open Access

Relationship of HS CRP and sacroiliac joint inflammation in undifferentiated spondyloarthritis

Te-Jung Liu , Cheng-Chiang Chang , Liang-Cheng Chen , Heng-Yi Chu , Chun-Sheng Hsu und Shin-Tsu Chang

Veröffentlicht/Copyright: 19. Mai 2018

Veröffentlicht von

Veröffentlichen auch Sie bei De Gruyter Brill

Manuskript einreichen Informationen für Autor*innen Erkunden Sie dieses Fachgebiet

Aus der Zeitschrift Open Medicine Band 13 Heft 1

Abstract

Objective

Elevation of serum high sensitivity C-reactive protein (hs-CRP) level has been demonstrated as a risk factor for varying diseases, as well as a biomarker for predicting recovery after operation of lumber disc herniation. Our objective was to investigate the relationship between serum hs-CRP and sacroiliac (SI) joint inflammation in patients with undifferentiated spondyloarthritis (uSpA).

Methods

In this retrospective study, we enrolled patients with uSpA who underwent hs-CRP testing between January 2007 and September 2013. Serum hs-CRP was analyzed at our central laboratory. All enrolled patients underwent skeletal scintigraphic scan with quantitative sacroiliac measurement.

Results

A total of 29 patients were enrolled with mean age 32.27 years and female:male ratio of 6:23. Pearson’s correlation coefficient showed a significant difference between hs-CRP in serum and SI/S ratio in uSpA, particularly the middle part of the sacroiliac joint, either right side or left side. The significantly high concentration of serum hs-CRP might indicate a systemic inflammatory response to flare-up of the SI joint and might be an indicator of SI inflammation in uSpA.

Keywords: High sensitivity C-reactive protein; Sacroiliac joint; Biomarker; Undifferentiated spondyloarthritis; Quantitative sacroiliac scintigraphy

1 Introduction

Elevation of serum high sensitivity C-reactive protein (hs-CRP) level has been demonstrated as a risk factor for heart failure [1], acute stroke [2], infective endocarditis [3], and diabetic nephropathy [4]. Chronic lower back pain is associated with impaired quality of life, loss of productivity and vast expenses of health care [5]. Lumber disc herniation (LDH) is one of contributing factors for chronic lower back pain [6], and some studies have confirmed the relationship between hs-CRP and LDH. For instance, two studies found that high concentration of hs-CRP measured before intervention for LDH, either operation or injection therapy, strongly indicates poor or less recovery [7,8]. However, a study from Korea did not support the relationship between hs-CRP and many diseases contributing chronic low back pain, including LDH [9].

Undifferentiated spondyloarthritis (uSpA) is a term used to describe symptoms and signs of spondylitis in someone who does not meet the criteria for a definitive diagnosis of AS or related disease. Patients with uSpA often develop chronic lower back pain [10]. The sacroiliac (SI) joint is most frequently involved. We assumed that serum hs-CRP could be a blood biomarker in uSpA. We investigated if serum hs-CRP level correlated with SI joint flare upin uSpA, and further if there was any relationship with varying parts of SI joint(s).

2 Materials and methods

2.1 Patients and methods

We retrospectively enrolled patients in a data bank in a medical center, who were confirmed as having a diagnosis of uSpA (codes M4600-M4609, M4680-M4689, M4690-M4699 in the International Classification of Diseases, 10^th Revision, Clinical Modification) during the period of January 2007 to December 2013, and those patients underwent testing of erythrocyte sedimentation rate (ESR) and hs-CRP at the central laboratory, as well as musculoskeletal bone scanning and quantitative sacroiliac scintigraphy (QSS). Exclusion criteria included medical history of major surgery, malignant neoplasm, tumor metastasis, metabolic/endocrine disease, and prolonged immobility or cachexia.

2.2 Measurement of ESR, hs-CRP and SI joint inflammation

The ESR and hs-CRP tests were conducted at the central hospital laboratory, and the latter was analyzed by IMMAGE® Immunochemistry Systems (BECKMAN COULTER, USA). The system comprised an infrared particle immunoassay, and the normal range was less than 0.1mg/dL [11].

SI joint disorder was measured by QSS, which was performed by using injection of 750 MBq 99mTc methylene diphosphonate intravenously. Planar imaging of the sacrum and SI joints was performed 3–4 hours after injection, with image acquisition around the SI joints using a single-head rotating gamma camera (IGE Starcam; GE Medical Systems, Milwaukee, WI, USA). Using the region-of-interest method, a quantitative SI joint to sacrum ratio (SI/S ratio) was measured from the ratio between total number of counts for the region derived from the SI joint and an identical level region derived from the sacrum. The ratio for the upper, middle, and lower parts of both joints was measured individually (Fig. 1). The equipment for QSS is available in our Department of Nuclear Medicine, and the reference data have been published [12,13].

Figure 1

Representative images with sacroiliac joint disorder using quantitative sacroiliac scintigraphy in case 15 (Y.-T.G.) with undifferentiated spondyloarthritis. Measurement of the ratio between total number of counts from the right and left sacroiliac (SI) joints divided by sacrum (S) for each is calculated as SI/S ratio (right panel). The ratio for the upper, middle, and lower parts of both joints was measured separately, showing 0.89339, 1.27269, and 1.3859 in the left-sided joint (mean = 1.3859), and 0.82411, 1.11394, and 1.20552 (mean = 1.20552) in the right-sided joint.

2.3 Data analysis and statistics

The data were recorded and stored digitally. Statistical analyses were performed using SAS software (version 9.13; SAS, Cary, NC, USA). Pearson correlation coefficient was used to assess relationships among ESR, hs-CRP and SI/S ratio at the left and right sides and at various parts (upper, middle, lower part). A p value ≤ 0.05 was considered to represent statistical significance.

2.4 Ethics statement

The research protocol (TSGHIRB, No. 2-102-05-021) was approved by the Institutional Review Board of Tri-Service General Hospital. The study conformed to the principles of the Declaration of Helsinki. With the approval of the Institutional Review Board, informed consent was waived due to the retrospective nature of the study.

3 Results

A total of 29 patients were enrolled in our study. The number of male patients was approximately 4-fold higher than the number of female patientsd and the mean age of the study group was around 32 years old. Table 1 shows the demographic characteristics of the enrolled patients. Pearson’s correlation coefficient showed no significant relationship between ESR and the varying parts of the SI joints (all p > 0.05; Table 2). However, Pearson’s correlation coefficient showed a significant relationship between hs-CRP and the middle part of the SI joint, either right side or left side (0.519 vs p=0.024 and 0.540 vs p=0.020, respectively; Table 3).

Table 1

Demographic characteristics of enrolled patients (N = 29; Female = 6, Male = 23)

Variable	Mean	SD	Minimum	Maximum
Age (year)	32.27	13.81	20	78
Serum hs-CRP (mg/dL)	0.21	0.12	0.04	0.41
ESR (mm/hr)	29	18	6	52
SI/S ratio
RU	1.25	0.35	0.74	2.25
RM	1.31	0.14	0.93	1.98
RL	1.23	0.36	0.84	1.91
LU	1.37	0.54	0.77	2.13
LM	1.34	0.16	0.89	1.96
LL	1.28	0.46	0.77	1.97

SI/S ratio: the quantitative ratio derived from the counting number of the sacroiliac (SI) joint divided by that of sacrum (S)
ESR = erythrocyte sedimentation rate
hs-CRP = high sensitivity C-reactive protein
Region of SI joint inflammation: RU: right upper; RM: right middle;
RL: right lower; LU: left upper; LM: left middle; LL: left lower.

Table 2

Pearson’s correlation coefficient for ESR and SI/S ratio at different parts.

	Pearson’s correlation coefficient	p-value
SI/S ratio of varying parts
RU	-0.087	0.473
RM	0.623	0.064
RL	0.264	0.372
LU	0.132	0.481
LM	0.548	0.121
LL	0.351	0.176

^∗p< 0.05 = statistically significant.
SI/S ratio: the quantitative ratio derived from the counting number of the sacroiliac (SI) joint divided by that of sacrum (S).
ESR = erythrocyte sedimentation rate
Region of SI joint inflammation: RU: right upper; RM: right middle;
RL: right lower; LU: left upper; LM: left middle; LL: left lower.

Table 3

Pearson’s correlation coefficient for hs-CRP and SI/S ratio at different parts.

	Pearson’s correlation coefficient	p-value
SI/S ratio of varying parts
RU	-0.076	0.364
RM	0.519	0.024^[*]
RL	0.107	0.283
LU	0.021	0.350
LM	0.540	0.020^[*]
LL	0.251	0.133

SI/S ratio: the quantitative ratio derived from the counting number of the sacroiliac (SI) joint divided by that of sacrum (S).
hs-CRP = high sensitivity C-reactive protein
Region of SI joint inflammation: RU: right upper; RM: right middle;
RL: right lower; LU: left upper; LM: left middle; LL: left lower.

4 Discussion

Sugimori et al. [7] found a positive correlation between the concentration of hs-CRP before operation and the Japanese Orthopaedic Association score after operation, and concluded that a higher concentration of hs-CRP before operation showed a poorer recovery after operation. Ackerman & Zhang [8] examined inflammatory serum markers and pain responses to lumbar epidural steroid injections in patients with LDH, and found that the higher the hs-CRP levels prior to the injection therapy, the less improvement in pain scores seen following the injection therapy. They suggested that elevated hs-CRP level is useful for objectively predicting response to the steroid injection in those patients with LDH with lower extremity radiculitis [8]. Although there is no direct anatomic linkage between LDH and SI joint, our results showed a significant difference between serum level of hs-CRP and the bilateral SI joints. To the best of our knowledge, this is the first study to confirm the relationship between hs-CRP in serum and SI/S ratio in uSpA, particularly in middle part of bilateral SI joints.

The strong correlation between hs-CRP and SI/S ratio may provide some guidance when we face patients with uSpA, particularly tenderness at the middle part of SI joint, (e.g. positive Fortin’s finger sign). Serum hs-CRP might indicate some kind of inflammatory condition occurring in the joint. We speculate that the middle part of the SI joint might exert a kind of reaction in response to elevation of serum hs-CRP and vice versa. Back pain is common in the general population and inflammation is an immune or biological reaction most commonly activated by cytokines [14,15]. The serum hs-CRP level might act as a blood biomarker for development of SI joint inflammation in uSpA. The worldwide rheumatologists have accepted the fact that elevated CRP is part of the classification criteria of non-radiographic SpA [16,17,18].

The term uSpA is used to describe symptoms and signs of spondylitis in someone who does not meet the criteria for a definitive diagnosis of ankylosing spondylitis (AS) or related disease(s). Sometimes a doctor may make an initial diagnosis of spondyloarthropathy or uSpA if certain symptoms are present but are not enough to make a specific diagnosis. Many people with uSpA have been told over the years that they are simply “anxious and depressed” or received a diagnosis of fibromyalgia, a chronic disorder associated with widespread muscle and soft tissue pain. Over time, some people with uSpA will develop a well-defined form of spondylitis such as AS. Some doctors consider uSpA a “cousin” to AS, psoriatic arthritis, spondylitis associated with inflammatory bowel/Crohn’s disease, and reactive arthritis. The presence of concomitant uSpA and sarcoidosis has been reported [19]. The development of uSpA in patients with sarcoidosis should forewarn physicians to the possibility of more than one form of spondyloarthropathy, and a relevant association between these two disorders or their coexistence may cause diagnostic challenges [19].

The etiology of uSpA can be attributed as inflammatory/infectious in origin. HLA-B27 has been shown to be a biomarker of AS [20]. Some authors have conducted DNA analyses on synovial cells collected from patients with sacroiliitis to investigate the link between infection and joint inflammation in patients with sacroiliitis [21,22]. Animal studies have revealed that X gene might be related to the development of sacroiliitis or spondylitis in mice [23]. However, it is hard to say which the etiology would link to uSpA right now due to limited information.

A recent study confirmed that uSpA is a severe and anti-TNF-responsive phenotypic subtype of spondyloarthritis. Patients with uSpA always exhibit a mixed axial (inflammatory back pain in 87.5%) and peripheral (peripheral arthritis in 62.5%) phenotype, with almost half of the patients having low-grade sacroiliitis on conventional plain films. The overall disease activity in uSpA is similar to AS and higher than in psoriatic arthritis. Initiation of TNF blockade significantly decreases disease activity in uSpA, with a similar amplitude to that in AS and psoriatic arthritis [24].

In regards to metabolism, uSpA showed a distinct difference compared with AS. In a study evaluating plasma vitamin D (vit D) level and its association with disease activity in two kinds of patient population, the results showed the plasma vitamin D levels were 18 μg/L (8-38) in the AS group, 20 μg/L (4-92.3) in the uSpA group and 24.3 μg/L (7.2-76.8) in the control group. Surprisingly, the vitamin D levels were inversely related to both ESR and C-reactive protein (CRP) in the AS patients (p=0.002, R=-0.428; p<0.001, R=-0.592, respectively); however, the correlation was not observed in the uSpA patients [25].

Articular involvement of inflammation of the SI joint in uSpA is not rare. A case report of a 43-year-old man with uSpA reports that he presented with history of recurrent episodes of anterior uveitis and progressive limping secondary to lower back and buttock pain. Initially he showed only mild tenderness and swelling of the right midfoot, and the magnetic resonance imaging of the lumbosacral spine was consistent with left sacroiliitis [26].

Involvement of the middle part of the SI joint in relationship with high hs-CRP is of interest. The SI joint is a true but not typical diarthrodial joint and is composed of fibrocartilage in addition to hyaline cartilage [27]. The synovial portion of the SI joint, shaped like an auricular “L”, is more anterior in position and the syndesmotic portion is more posterior [28]. The SI joint acts as “self-bracing mechanisms” because of its corkscrew shape created by the different wedge angles in transverse cross-sections at the cranial and caudal ends of the joint, which provide resistance to sliding [29,30]. We believe that the self-bracing mechanisms can be damaged by inflammation, which occurring in the middle part of the joint was more obvious than in other parts. Furthermore, inflammation at the SI joint occurred simultaneously together with elevation of serum hs-CRP level.

This study has a number of limitations, including its retrospective design, lack of follow-up and small patient numbers. Further study is necessary to explore the relationship between serum hs-CRP and uSpA.

In conclusion, there was an association between hs-CRP in serum and SI/S ratio in uSpA, particularly in middle part of bilateral SI joints. The significantly high concentration of serum hs-CRP might indicate a systemic inflammatory response to flair-up of SI joint and might act as a biomarker to indicate development of SI joint inflammation in uSpA.

Acknowledgements

The authors would like to thank the reviewers of this paper for the invaluable comments and their host institution for the opportunity to pursue this research. This research project was supported by Scientific Research Grant No. AFTYGH-10607 provided by the Taoyuan Armed Forces General Hospital, Taiwan (Dr. TE-JUNG LIU).

Declaration of conflicting interests: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

References

[1] Braunwald E. Biomarkers in heart failure. N Engl J Med 2008;358:2148-215910.1056/NEJMra0800239Suche in Google Scholar PubMed

[2] Gotto AM, Jr., Moon JE. Management of cardiovascular risk: the importance of meeting lipid targets. Am J Cardiol 2012;110:3A-14A10.1016/j.amjcard.2012.04.002Suche in Google Scholar PubMed

[3] Gunebakmaz O, Kaya MG, Kaya EG, Ardic I, Yarlioglues M, Dogdu O, kalay N, Akpek M, Sarli B, Ozdogru I. Mean platelet volume predicts embolic complications and prognosis in infective endocarditis. Int J Infect Dis 2010;14:e982-e98510.1016/j.ijid.2010.05.019Suche in Google Scholar PubMed

[4] Hellemons ME, Kerschbaum J, Bakker SJ, Neuwirt H, Mayer B, Mayer G, de Zeeuw D, Lambers Heerspink HJ, Rudnicki M. Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review. Diabet Med 2012;29:567-57710.1111/j.1464-5491.2011.03437.xSuche in Google Scholar PubMed

[5] Kulkarni AG, Diwan AD. Prosthetic lumbar disc replacement for degenerative disc disease. Neurol India 2005;53:499-50510.4103/0028-3886.22620Suche in Google Scholar PubMed

[6] Majlesi J, Togay H, Unalan H, Toprak S. The sensitivity and specificity of the Slump and the Straight Leg Raising tests in patients with lumbar disc herniation. J Clin Rheumatol 2008;14:87-9110.1097/RHU.0b013e31816b2f99Suche in Google Scholar PubMed

[7] Sugimori K, Kawaguchi Y, Morita M, Kitajima I, Kimura T. High-sensitivity analysis of serum C-reactive protein in young patients with lumbar disc herniation. J Bone Joint Surg Br 2003;85:1151-115410.1302/0301-620X.85B8.14538Suche in Google Scholar PubMed

[8] Ackerman WE 3rd, Zhang JM. Serum hs-CRP as a useful marker for predicting the efficacy of lumbar epidural steroid injections on pain relief in patients with lumbar disc hernia tions. J Ky Med Assoc 2006;104:295-299Suche in Google Scholar

[9] Park CH, Lee SH. Investigation of high-sensitivity c-reactive protein and erythrocyte sedimentation rate in low back pain patients. Korean J Pain 2010;23:147-15010.3344/kjp.2010.23.2.147Suche in Google Scholar PubMed PubMed Central

[10] Deyo RA, Weinstein JN. Low back pain. N Engl J Med 2001;344:363-37010.1056/NEJM200102013440508Suche in Google Scholar PubMed

[11] Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-51110.1161/01.CIR.0000052939.59093.45Suche in Google Scholar PubMed

[12] Guan SI, Chu LS, Hwang WS, Chen WL. The differential diagnosis of benign and malignant bony lesions in bone scanning. Using the ratio of radiouptake at different times. Clin Nucl Med 1990;15:424-42710.1097/00003072-199006000-00013Suche in Google Scholar

[13] Chang ST, Ku CH, Cherng SC. Evidence-based correlation between anti-streptolysin O serum titer and sacroiliac joint disorder. J Rheumatol 2007;34:1746-1752Suche in Google Scholar

[14] Anderson JM. Biological responses to materials. Annu Rev Mater Res 2001;31:81-11010.1146/annurev.matsci.31.1.81Suche in Google Scholar

[15] Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol 2008;20:86-10010.1016/j.smim.2007.11.004Suche in Google Scholar

[16] Poddubnyy DA, Rudwaleit M, Listing J, Braun J, Sieper J. Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. Ann Rheum Dis 2010;69:1338-134110.1136/ard.2009.120139Suche in Google Scholar

[17] Navarro-Compán V, van der Heijde D, Combe B, Cosson C, van Gaalen FA. Value of high-sensitivity C-reactive protein for classification of early axial spondyloarthritis: results from the DESIR cohort. Ann Rheum Dis 2013;72:785-78610.1136/annrheumdis-2012-202504Suche in Google Scholar

[18] Machado P, Navarro-Compán V, Landewé R, van Gaalen FA, Roux C, van der Heijde D. Calculating the ankylosing spondylitis disease activity score if the conventional c-reactive protein level is below the limit of detection or if high-sensitivity c-reactive protein is used: an analysis in the DESIR cohort. Arthritis Rheumatol 2015;67:408-41310.1002/art.38921Suche in Google Scholar

[19] Kara M, Özçakar L, Kalyoncu F, Akinci A. Early undifferentiated spondyloarthropathy in a patient with sarcoidosis. Turk J Rheumatol 2013;28:206-20810.5606/tjr.2013.3000Suche in Google Scholar

[20] Ehrenfeld M. Spondyloarthropathies. Best Pract Res Clin Rheumatol 2012;26:135-14510.1007/978-1-60327-285-8_38Suche in Google Scholar

[21] Wilkinson NZ, Kingsley GH, Sieper J, Braun J, Ward ME. Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response. Arthritis Rheum 1998;41:845-85410.1002/1529-0131(199805)41:5<845::AID-ART11>3.0.CO;2-PSuche in Google Scholar

[22] Wilkinson NZ, Kingsley GH, Jones HW, Sieper J, Braun J, Ward ME. The detection of DNA from a range of bacterial species in the joints of patients with a variety of arthritides using a nested, broad-range polymerase chain reaction. Rheumatology (Oxford) 1999;38:260-26610.1093/rheumatology/38.3.260Suche in Google Scholar

[23] Shi S, Ciurli C, Cartman A, Pidoux I, Poole AR, Zhang Y. Experimental immunity to the G1 domain of the proteoglycan versican induces spondylitis and sacroiliitis, of a kind seen in human spondylarthropathies. Arthritis Rheum 2003;48:2903-291510.1002/art.11270Suche in Google Scholar

[24] Paramarta JE, De Rycke L, Ambarus CA, Tak PP, Baeten D. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment. Rheumatology (Oxford) 2013;52:1873-187810.1093/rheumatology/ket239Suche in Google Scholar

[25] Erten S, Kucuksahin O, Sahin A, Altunoglu A, Akyol M, Koca C. Decreased plasma vitamin D levels in patients with undifferentiated spondyloarthritis and ankylosing spondylitis. Intern Med 2013;52:339-34410.2169/internalmedicine.52.9047Suche in Google Scholar

[26] Lin RJ, Curran JJ, Zimmerman TM, Song J, Niewold TB, Sweiss NJ. Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma. J Clin Rheumatol 2010;16:90-9110.1097/RHU.0b013e3181d0bfefSuche in Google Scholar

[27] Forst SL, Wheeler MT, Fortin JD, Vilensky JA. The sacroiliac joint: anatomy, physiology and clinical significance. Pain Physician 2006;9:61-6710.36076/ppj.2006/9/62Suche in Google Scholar

[28] Liebenson C. The relationship of the sacroiliac joint, stabilization musculature, and lumbo-pelvic instability. J Bodyw Mov Ther 2004;8:43-4510.1016/S1360-8592(03)00090-1Suche in Google Scholar

[29] Snijders CJ, Stoeckart R, Vleeming A. Transfer of lumbosacral load to iliac bones and legs Part 1: Biomechanics of self-bracing of the sacroiliac joints and its significance for treatment and exercise. Clin Biomech 1993;8:285-29410.1016/0268-0033(93)90002-YSuche in Google Scholar

[30] Snijders CJ, Stoeckart R, Vleeming A. Transfer of lumbosacral load to iliac bones and legs part 2: loading of the sacroiliac joints when lifting in a stooped posture. Clin Biomech 1993;8:295-30110.1016/0268-0033(93)90003-ZSuche in Google Scholar

Received: 2017-10-28

Accepted: 2018-02-27

Published Online: 2018-05-19

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Artikel in diesem Heft

https://doi.org/10.1515/med-2018-0018

Schlagwörter für diesen Artikel

High sensitivity C-reactive protein; Sacroiliac joint; Biomarker; Undifferentiated spondyloarthritis; Quantitative sacroiliac scintigraphy

Creative Commons

BY-NC-ND 4.0